unknown
Stage
1
Investors
About
Avedro is a commercial-stage ophthalmic medical technology company that develops devices and drug formulations for corneal cross-linking to treat corneal ectatic disorders and improve vision, reducing reliance on eyeglasses or contact lenses.
Explore Avedro's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.